Kazia Therapeutics
Kazia is a biotechnology firm that develops and commercializes drugs for the treatment of cancer.
Business Model:
Revenue: $11.4M
Employees: 2-10
Detailed Kazia Therapeutics Information
Geographic Data
Address: 300 Barangaroo Avenue
City: Sydney
State: new south wales
Zip: 2000
Country: AU
Financial Info
Stage:
post ipo equity
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
3,989,341Website Global Rank
2,757Website Monthly Traffic
Twitter Followers
Description
Kazia is a biotechnology firm that develops and commercializes drugs for the treatment of cancer.
Contact Phone:
Contact Email:
Kazia Therapeutics went public on 1/8/1999 on the Australian Securities Exchange
Listed Exchange:
Australian Securities Exchange
IPO Date:
1/8/1999
Ticker Symbol:
KZA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2019 | Private Placement | $2.7M | 1/2023 | Post-IPO Equity | $3.1M | 7/2013 | Post-IPO Equity | $4.5M | 4/2020 | Post-IPO Equity | $1.1M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 10/2016 | Glioblast Pty Ltd |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
